162 related articles for article (PubMed ID: 9696852)
1. The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry.
Basavappa R; Gómez-Yafal A; Hogle JM
J Virol; 1998 Sep; 72(9):7551-6. PubMed ID: 9696852
[TBL] [Abstract][Full Text] [Related]
2. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.
Strauss M; Filman DJ; Belnap DM; Cheng N; Noel RT; Hogle JM
J Virol; 2015 Apr; 89(8):4143-57. PubMed ID: 25631086
[TBL] [Abstract][Full Text] [Related]
3. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.
Hindiyeh M; Li QH; Basavappa R; Hogle JM; Chow M
J Virol; 1999 Nov; 73(11):9072-9. PubMed ID: 10516013
[TBL] [Abstract][Full Text] [Related]
4. Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles.
Tuthill TJ; Bubeck D; Rowlands DJ; Hogle JM
J Virol; 2006 Jan; 80(1):172-80. PubMed ID: 16352541
[TBL] [Abstract][Full Text] [Related]
5. A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.
Moscufo N; Yafal AG; Rogove A; Hogle J; Chow M
J Virol; 1993 Aug; 67(8):5075-8. PubMed ID: 8392631
[TBL] [Abstract][Full Text] [Related]
6. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution.
Basavappa R; Syed R; Flore O; Icenogle JP; Filman DJ; Hogle JM
Protein Sci; 1994 Oct; 3(10):1651-69. PubMed ID: 7849583
[TBL] [Abstract][Full Text] [Related]
7. Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition.
Colston EM; Racaniello VR
J Virol; 1995 Aug; 69(8):4823-9. PubMed ID: 7609049
[TBL] [Abstract][Full Text] [Related]
8. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.
Belnap DM; Filman DJ; Trus BL; Cheng N; Booy FP; Conway JF; Curry S; Hiremath CN; Tsang SK; Steven AC; Hogle JM
J Virol; 2000 Feb; 74(3):1342-54. PubMed ID: 10627545
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
Ansardi DC; Luo M; Morrow CD
Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
[TBL] [Abstract][Full Text] [Related]
10. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
[TBL] [Abstract][Full Text] [Related]
11. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
Ansardi DC; Morrow CD
J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
[TBL] [Abstract][Full Text] [Related]
12. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
Ansardi DC; Morrow CD
J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
[TBL] [Abstract][Full Text] [Related]
13. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.
Fricks CE; Hogle JM
J Virol; 1990 May; 64(5):1934-45. PubMed ID: 2157861
[TBL] [Abstract][Full Text] [Related]
14. Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.
Liao S; Racaniello V
J Virol; 1997 Dec; 71(12):9770-7. PubMed ID: 9371643
[TBL] [Abstract][Full Text] [Related]
15. Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release.
Butan C; Filman DJ; Hogle JM
J Virol; 2014 Feb; 88(3):1758-70. PubMed ID: 24257617
[TBL] [Abstract][Full Text] [Related]
16. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.
Colston E; Racaniello VR
EMBO J; 1994 Dec; 13(24):5855-62. PubMed ID: 7813425
[TBL] [Abstract][Full Text] [Related]
17. An externalized polypeptide partitions between two distinct sites on genome-released poliovirus particles.
Lin J; Cheng N; Chow M; Filman DJ; Steven AC; Hogle JM; Belnap DM
J Virol; 2011 Oct; 85(19):9974-83. PubMed ID: 21775460
[TBL] [Abstract][Full Text] [Related]
18. Cleavage sites within the poliovirus capsid protein precursors.
Larsen GR; Anderson CW; Dorner AJ; Semler BL; Wimmer E
J Virol; 1982 Jan; 41(1):340-4. PubMed ID: 6283126
[TBL] [Abstract][Full Text] [Related]
19. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Dove AW; Racaniello VR
J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
[TBL] [Abstract][Full Text] [Related]
20. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions.
Duncan G; Pelletier I; Colbère-Garapin F
Virology; 1998 Feb; 241(1):14-29. PubMed ID: 9454713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
